MergerLinks Header Logo

Request Deal Involvement

Brookfield Capital Partners completed the acquisition of Antylia Scientific from GTCR for $1.4bn.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

Baker McKenzie

legal advisors

Baker McKenzie

UBS

financial advisors

UBS

Milbank

legal advisors to financial advisors

Milbank

Simpson Thacher & Bartlett

legal advisors

Simpson Thacher & Bartlett

Barclays

financial advisors

Barclays

Goldman Sachs

financial advisors

Goldman Sachs

Kirkland & Ellis

legal advisors

Kirkland & Ellis

Jefferies & Company

financial advisors

Jefferies & Company

Prosek Partners

pr advisors

Prosek Partners

JP Morgan

financial advisors

JP Morgan

or

Principals

BROOKFIELD ASSET MANAGEMENT

bidder

BROOKFIELD ASSET MANAGEMENT

ANTYLIA SCIENTIFIC (EX COLE-PARMER INSTRUMENT COMPANY)

target

ANTYLIA SCIENTIFIC (EX COLE-PARMER INSTRUMENT COMPANY)

GTCR LLC

vendor

GTCR LLC

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite

MergerLinks - Request Credit - Brookfield Capital Partners completed the acquisition of Antylia Scientific from GTCR for $1.4bn.